StonvexLoading…
StonvexStonvexStonvexCore line items from MGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.45B | $17.54B | $12.93B | $8.68B |
Operating Income | $301.24M | $1.00B | $676.77M | $789.62M |
Net Income | $125.14M | $205.86M | $-87.75M | $197.50M |
EPS (Diluted) | $0.48 | $0.76 | $-0.32 | $0.70 |
Total Assets | $41.40B | $41.37B | $41.41B | $41.70B |
Total Liabilities | $38.07B | $38.10B | $37.96B | $37.96B |
Cash & Equivalents | $2.29B | $2.06B | $2.13B | $1.96B |
Free Cash Flow OCF − CapEx | $413.13M | $1.46B | $1.10B | $696.47M |
Shares Outstanding | 255.85M | 258.32M | 272.21M | 272.18M |